Stay updated with breaking news from Ejada System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Full year 2023 revenue of $6.3 billion, up 1% as-reported and 3% at constant currency Full year 2023 diluted earnings per share of $3.99 and non-GAAP Adjusted diluted earnings per share of...
An intrauterine vacuum-induced hemorrhage-control device provided prompt and effective management of bleeding in cases of obstetric hemorrhage.
14.09.2023 - Organon (NYSE: OGN), a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), ...
The first WNY patient to be saved by a new device to stop a hemorrhage after childbirth returned to the hospital with her baby one year later to thank her doctors.
The Ministry of Labour announced the approval of a system of incentives and gratuities for all departments linked to Ejada System, as well as rewards for outstanding performers (workers) who excelled during 2022.